Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.874
|
0.908
|
0.799
|
0.7985
|
0.80
|
0.7985
|
|
|
|
|
0.794
|
0.825
|
0.7985
|
0.7985
|
0.814
|
0.814
|
|
|
|
|
0.7465
|
0.7755
|
0.745
|
0.745
|
0.751
|
0.751
|
|
|
|
|
0.745
|
0.774
|
0.746
|
0.746
|
0.7495
|
0.7495
|
|
|
|
|
0.75
|
0.779
|
0.6995
|
0.6995
|
0.777
|
0.777
|
|
|
543.90
|
5.00
|
0.7005
|
0.7285
|
0.758
|
0.7305
|
0.766
|
0.7305
|
|
|
|
|
0.734
|
0.763
|
0.6785
|
0.6775
|
0.683
|
0.683
|
|
|
|
|
0.6815
|
0.708
|
0.684
|
0.673
|
0.684
|
0.673
|
|
|
|
|
0.6785
|
0.705
|
0.648
|
0.648
|
0.6755
|
0.6755
|
|
|
|
|
0.66
|
0.6855
|
0.6825
|
0.6815
|
0.697
|
0.697
|
|
|
|
|
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States.